rHSA-IFN Alpha-2b (Anhui Anke Biotechnology/Anhui Medical University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerHSA-IFN Alpha-2b (Anhui Anke Biotechnology/Anhui Medical University)
Drug Alias NamerHSA-IFN Alpha-2b (Anhui Anke Biotechnology/Anhui Medical University)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterferon alpha 2 ligand
TargetsInterferon alpha-2
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesAnhui Medical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnhui Medical UniversityAnhui Anke Biotechnology (Group) Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A